HSAI dropped 9% on May 19 despite reporting its strongest quarter in years, and the gap between what the numbers said and what the stock did frames the whole week's story.
Q1 revenue rose to $98.7 million from $72.4 million a year earlier. Adjusted EPS came in at $0.04, up from $0.01. The company swung to an RMB 18.3 million net profit. Management guided Q2 sales between $123 million and $130 million. On any objective reading, that is a confident set of numbers from a Chinese lidar manufacturer in a sector that has historically struggled to prove commercial viability. The stock fell anyway — down 10.8% on the day of the earnings release and a further leg lower by session close.
The borrow market tells a nuanced story heading into that print. Availability had been tightening steadily through the first half of May, dropping to a 52-week low of around 23% on May 12 — meaning fewer than one share was available to borrow for every four already shorted. That is firmly in "tight" territory and reflects a market that had built up a meaningful short position going into earnings. By May 19, availability had loosened slightly to 49%, still well below the 80%-plus levels seen in mid-April, suggesting the borrow pool remains constrained relative to recent history. Short interest has trended lower from its late-April peak above 6.47 million shares to roughly 5.5 million, a reduction of around 15% — but the direction of that covering did not translate into price support when the results landed.
Options traders had already pivoted sharply away from defensive positioning ahead of the print. The put/call ratio fell to 0.49 on May 19, almost 1.6 standard deviations below its 20-day average of 0.64. For most of April and early May, the PCR had been running in the high 0.60s to low 0.70s, consistent with cautious sentiment. The abrupt shift toward calls in the week before earnings pointed to a degree of speculative positioning for a positive surprise — which arrived, but failed to deliver the expected repricing.
The analyst picture is mixed and carries some caution around currency and valuation. The mean price target listed in the data runs to approximately $205, which appears inconsistent with a stock trading at $20 and should be treated with caution — it likely reflects a stale data point or a listing confusion involving the Hong Kong-traded equivalent. The coverage that does look current paints a more grounded picture: Goldman Sachs held a Buy with a $36 target in September 2025, Morgan Stanley upgraded to Overweight with a $26 target in July 2025, and UBS initiated Buy at $35 in August 2025. Those targets are now six to nine months old and sit roughly 30-75% above the current price — which captures the Street's structural optimism but also the persistent gap between analyst conviction and market reality for a China-listed name with US-listed ADRs. Amerx initiated a Hold on May 11 and reiterated it today, adding a neutral voice to that backdrop. The EPS surprise factor score ranks in the 94th percentile — among the strongest in the universe on that metric — but the forward EPS growth score ranks in just the 8th percentile, reflecting analyst caution about how durable the margin improvement will be.
Institutional activity adds an interesting dimension. Vanguard added 4.3 million shares in the quarter through March, and FMR (Fidelity) built a 3.3 million share position with the most recent filing dated May 11. BlackRock added 4.5 million shares through April. The co-founder and management group still collectively hold around 17% of the company. That combination of insider concentration and systematic fund accumulation suggests the stock's ownership base is not fragile — but nor has that buying translated into upward price pressure in recent weeks, with the stock down 14% over the past month. Notably, Hesai also announced a design win from a top European OEM adding a one-million-unit order and confirmed a strategic lidar partnership with Mercedes-Benz for L3-enabled models — two pieces of commercial news that would typically be read as de-risking the revenue outlook.
The short score of 56.9, while elevated, has eased modestly from a recent high near 59 in early May, consistent with some covering. Cost to borrow remains low at 0.86%, up 24% over the past month but still inexpensive in absolute terms — this is not a name where bears are paying to hold their positions. The key tension heading into the next few weeks is whether the gap between Q1's strong operational delivery, the new OEM wins, and a stock that is down 14% on the month begins to close — or whether macro concerns around China-linked tech and a still-constrained borrow pool continue to weigh on the re-rating.
See the live data behind this article on ORTEX.
Open HSAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
